|
|
|
MERRIMACK – Chuck and Jackie Rossier call themselves survivors. In the last 10 years, the couple have battled through three bouts of cancer. But they said one of the biggest struggles was navigating the complex and exceedingly...
Consortium moves closer to building proton beam therapy center in or near NYC as rivals outside city threaten to siphon off area patients; seen as a quasi arms race. New York City hospitals say they are moving closer to forming...
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today...
WACO, Texas - She claimed she had breast cancer, but now cops say it was all a big lie - she just wanted bigger breasts! Police have accused a Texas woman of lying about having breast cancer and spending $10,000 raised at a...
By Associated Press Friday, November 13, 2009 - Added 2m ago WACO, Texas - She claimed she had breast cancer, but now cops say it was all a big lie - she just wanted bigger breasts! Police have accused a Texas woman of lying...
Stories by ROSE YASMIN KARIM Pictures by NORAFIFI EHSAN & HUSM While prosthetics can transform an actor into a sci-fi creature, it makes looking into the mirror that much easier for people who are disfigured. Simply painting a...
Pathology and Laboratory Medicine and Pulmonary Biology, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio. Lung cancer is the leading cause of cancer deaths,...
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced...
Request a Trial to NEW EDGAR Online Pro Item 2. To date, more than 400 subjects have been treated to date with ZYBRESTAT in human clinical trials. In light of the significant human experience with ZYBRESTAT to date, and because...
Researchers at Wellington's Malaghan Institute are taking on a nasty, but rare illness -- lymphangioleiomyomatosis (LAM). The institute, funded by the NZ LAM Trust and the LAM Australasia Research Alliance, is investigating the...
